Qun Wang

Title: Innovations in Corneal Treatment by Qun Wang

Introduction

Qun Wang is an accomplished inventor based in Shandong, China. He has made significant contributions to the field of medical research, particularly in the treatment of corneal diseases. His innovative work focuses on the use of long-chain non-coding RNA NEAT1 for therapeutic applications.

Latest Patents

Qun Wang holds a patent for an adeno-associated virus designed to activate RNA-NEAT1 over-expression. This invention has promising applications in the preparation of drugs for treating Fuchs' endothelial corneal dystrophy. The overexpression of long-chain non-coding RNA NEAT1 can effectively reduce corneal endothelial damage and alleviate symptoms of corneal edema. This advancement offers a potential treatment for Fuchs' endothelial corneal malnutrition.

Career Highlights

Qun Wang is affiliated with the Eye Institute of Shandong First Medical University. His work at this institution has been pivotal in advancing research related to corneal health and innovative treatment methodologies. His dedication to improving patient outcomes through scientific research is commendable.

Collaborations

Qun Wang collaborates with notable colleagues, including Weiyun Shi and Qingjun Zhou. Their combined expertise enhances the research efforts at the Eye Institute, fostering an environment of innovation and discovery.

Conclusion

Qun Wang's contributions to the field of corneal treatment through his innovative patent demonstrate the potential of RNA-NEAT1 in medical applications. His work not only advances scientific knowledge but also holds promise for improving the quality of life for patients suffering from corneal diseases.